159 related articles for article (PubMed ID: 8603451)
1. Glutathione S-transferase and glutathione peroxidase are essential in the early stage of adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells.
Lee WP; Lee CL; Lin HC
Cancer Chemother Pharmacol; 1996; 38(1):45-51. PubMed ID: 8603451
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S
Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
4. Transduction of NIH 3T3 cells with a retrovirus carrying both human MDR1 and glutathione S-transferase pi produces broad-range multidrug resistance.
Doroshow JH; Metz MZ; Matsumoto L; Winters KA; Sakai M; Muramatsu M; Kane SE
Cancer Res; 1995 Sep; 55(18):4073-8. PubMed ID: 7664283
[TBL] [Abstract][Full Text] [Related]
5. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
6. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
7. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
8. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE
Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279
[TBL] [Abstract][Full Text] [Related]
9. Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin.
Beaumont PO; Moore MJ; Ahmad K; Payne MM; Lee C; Riddick DS
Cancer Res; 1998 Mar; 58(5):947-55. PubMed ID: 9500455
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin.
Lee WP; Lee CL; Kao MC
Biochem Biophys Res Commun; 1992 Nov; 189(1):92-100. PubMed ID: 1360209
[TBL] [Abstract][Full Text] [Related]
11. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
12. [Role of glutathione S-transferase pi in tumor drug resistance].
Cao W; Zuo J; Fang F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):402-6. PubMed ID: 12567441
[TBL] [Abstract][Full Text] [Related]
13. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK
Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
[TBL] [Abstract][Full Text] [Related]
14. A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin activity against human ovarian carcinoma cells.
Maeda O; Terasawa M; Ishikawa T; Oguchi H; Mizuno K; Kawai M; Kikkawa F; Tumoda Y; Hidaka H
Cancer Res; 1993 May; 53(9):2051-6. PubMed ID: 8097673
[TBL] [Abstract][Full Text] [Related]
15. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
16. Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines.
Whelan RD; Hosking LK; Townsend AJ; Cowan KH; Hill BT
Cancer Commun; 1989; 1(6):359-65. PubMed ID: 2702041
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines.
Benchekroun MN; Schneider E; Safa AR; Townsend AJ; Sinha BK
Mol Pharmacol; 1994 Oct; 46(4):677-84. PubMed ID: 7969046
[TBL] [Abstract][Full Text] [Related]
18. [The expression of GST pi mRNA in the P388/ADR and L1210/DDP resistant lines examined by synthetic probe].
Liu YB
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):264-7. PubMed ID: 8174463
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
Yang CZ; Luan FJ; Xiong DS; Liu BR; Xu YF; Gu KS
Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):333-7. PubMed ID: 7668104
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of glutathione S-transferase/glutathione peroxidase enhances the growth of transgenic tobacco seedlings during stress.
Roxas VP; Smith RK; Allen ER; Allen RD
Nat Biotechnol; 1997 Oct; 15(10):988-91. PubMed ID: 9335051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
